European Ophthalmic Pharmaceuticals Market

 


This research service analyses the European ophthalmic pharmaceuticals market. The base year is 2009 with forecasts running through 2016. The segments covered include: the European Glaucoma pharmaceuticals market, European AMD pharmaceuticals market , European Allergic Conjunctivitis pharmaceuticals market , European Diabetic Retinopathy pharmaceuticals market and the European Chronic Dry Eye pharmaceuticals market. It provides the patient forecasts and current treatment options for various ophthalmic diseases. It analyses market drivers, restraints and challenges faced by industry participants. Revenue forecasts and pipeline analysis has been discussed. In addition, it also provides strategic recommendations.

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

Table of Contents

European Ophthalmic Pharmaceuticals Market, Executive SummaryOverviewOverview of the European Ophthalmic Pharmaceuticals MarketEuropean Ophthalmic Pharmaceuticals Market, Glossary of TermsGlossary Glossary for the Total European Ophthalmic Pharmaceuticals Market European Ophthalmic Pharmaceuticals Market, Research MethodologyResearch Objectives and ScopeMethodologyAssumptions and LimitationsEuropean Ophthalmic Pharmaceuticals Market, Ophthalmic Disease OverviewIntroductionDisease CharacteristicsEuropean Ophthalmic Pharmaceuticals Market, Industry ChallengesChallenges for the Total European Ophthalmic Pharmaceuticals MarketKey Industry ChallengesEuropean Ophthalmic Pharmaceuticals Market, Market Trends and AnalysisMarket Engineering MeasurementsMarket Engineering Measurements for the Total European Ophthalmic Pharmaceuticals MarketMarket DriversMarket Drivers for the Total European Ophthalmic Pharmaceuticals MarketMarket RestraintsMarket Restraints for the Total European Ophthalmic Pharmaceuticals MarketEuropean Ophthalmic Pharmaceuticals Market, Total Forecasts for the European Ophthalmic Pharmaceuticals MarketRevenue ForecastsRevenue Forecasts for the European Ophthalmic Pharmaceuticals MarketEuropean Ophthalmic Pharmaceuticals Market, Glaucoma Pharmaceuticals MarketOverviewIntroductionPatient ForecastsCurrent Treatment OptionsPipeline AnalysisEuropean Ophthalmic Pharmaceuticals Market, Age-related Macular Degeneration Pharmaceuticals MarketOverviewIntroductionPatient ForecastsCurrent Treatment OptionsPipeline AnalysisEuropean Ophthalmic Pharmaceuticals Market, Allergic Conjunctivitis Pharmaceuticals MarketOverviewIntroductionPatient ForecastsCurrent Treatment OptionsPipeline AnalysisEuropean Ophthalmic Pharmaceuticals Market, Diabetic Retinopathy Pharmaceuticals MarketOverviewIntroductionPatient ForecastsCurrent Treatment OptionsPipeline AnalysisEuropean Ophthalmic Pharmaceuticals Market, Chronic Dry Eye Pharmaceuticals MarketOverviewIntroductionPatient ForecastsCurrent Treatment OptionsPipeline AnalysisEuropean Ophthalmic Pharmaceuticals Market, Strategic Recommendations Market Engineering Strategic RecommendationsStrategic Recommendations for the Total European Ophthalmic Pharmaceuticals MarketEuropean Ophthalmic Pharmaceuticals Market, Decision Support DatabasesDatabases for AnalysisTotal PopulationPopulation Above 65 YearsPer cent Population Above 65 YearsTotal Healthcare Expenditure Government Healthcare ExpenditurePrivate Healthcare ExpenditurePer Capita Healthcare Expenditure




Related Research

Release Date : 11-Aug-17

Region : Europe

Release Date : 08-Aug-17

Region : Europe

Release Date : 02-Aug-17

Region : Europe

Release Date : 25-Jul-17

Region : Europe

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.